These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 18588501)
21. Hematopoietic SCT in patients with a history of invasive fungal infection. Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496 [TBL] [Abstract][Full Text] [Related]
22. [Fungal prophylaxis following reduced-intensity stem cell transplantation (RIST)]. Kami M; Imataki O; Taniguchi S; Kanemaru M; Hayashi T Nihon Ishinkin Gakkai Zasshi; 2004; 45(4):189-202. PubMed ID: 15550915 [TBL] [Abstract][Full Text] [Related]
23. Is there a role for polyenes in treating invasive mycoses? Cornely OA; Vehreschild JJ; Ullmann AJ Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332 [TBL] [Abstract][Full Text] [Related]
24. Clinical practice: combination antifungal therapy for mold infections: much ado about nothing? Vazquez JA Clin Infect Dis; 2008 Jun; 46(12):1889-901. PubMed ID: 18466092 [TBL] [Abstract][Full Text] [Related]
25. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine? Hof H Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827 [TBL] [Abstract][Full Text] [Related]
26. What does preemptive antifungal treatment really mean? Stefani PM; Salvadori U; Gottardi M; Rigoli R; Scotton P; Gherlinzoni F Clin Infect Dis; 2010 Apr; 50(8):1201-2; author reply 1202. PubMed ID: 20233047 [No Abstract] [Full Text] [Related]
27. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings. Rieger CT; Rieger H; Kolb HJ; Peterson L; Huppmann S; Fiegl M; Ostermann H Transpl Infect Dis; 2009 Jun; 11(3):220-6. PubMed ID: 19298239 [TBL] [Abstract][Full Text] [Related]
28. Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach. Lehrnbecher T; Mousset S; Sörensen J; Böhme A Mycoses; 2009 Mar; 52(2):107-17. PubMed ID: 18983431 [TBL] [Abstract][Full Text] [Related]
29. Antifungals in Clinical Use and the Pipeline. Johnson MD Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281 [TBL] [Abstract][Full Text] [Related]
30. Fungal infections in pediatric intensive care units. Finco G; Sanna D; Evangelista M; Mura P; Musu M J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():21-3. PubMed ID: 21749271 [TBL] [Abstract][Full Text] [Related]
31. Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant. Mossad SB; Avery RK; Bolwell BJ Clin Infect Dis; 2003 Jun; 36(11):1503-4; author reply 1504. PubMed ID: 12766853 [No Abstract] [Full Text] [Related]
32. Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy. Slavin MA; Heath CH; Thursky KA; Morrissey CO; Szer J; Ling LM; Milliken ST; Grigg AP Intern Med J; 2008 Jun; 38(6b):468-76. PubMed ID: 18588520 [TBL] [Abstract][Full Text] [Related]
33. Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation. Neuburger S; Massenkeil G; Seibold M; Lutz C; Tamm I; le Coutre P; Graf B; Doerken B; Arnold R Transpl Infect Dis; 2008 Jul; 10(4):290-3. PubMed ID: 18194367 [TBL] [Abstract][Full Text] [Related]
35. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Tacke D; Buchheidt D; Karthaus M; Krause SW; Maschmeyer G; Neumann S; Ostermann H; Penack O; Rieger C; Ruhnke M; Sandherr M; Schweer KE; Ullmann AJ; Cornely OA Ann Hematol; 2014 Sep; 93(9):1449-56. PubMed ID: 24951122 [TBL] [Abstract][Full Text] [Related]
36. Infectious pulmonary complications after stem cell transplantation or chemotherapy: diagnostic yield of bronchoalveolar lavage. Bissinger AL; Einsele H; Hamprecht K; Schumacher U; Kandolf R; Loeffler J; Aepinus C; Bock T; Jahn G; Hebart H Diagn Microbiol Infect Dis; 2005 Aug; 52(4):275-80. PubMed ID: 15936168 [TBL] [Abstract][Full Text] [Related]
37. Current status and future of antifungal therapy for systemic mycoses. Nosanchuk JD Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):75-84. PubMed ID: 18221136 [TBL] [Abstract][Full Text] [Related]
38. [Clinical importance of azoles in antifungal therapy: treatment or prophylaxis with new azoles in hematology]. Vazquez Lopez L Rev Esp Quimioter; 2004 Mar; 17(1):98-100. PubMed ID: 15201932 [No Abstract] [Full Text] [Related]
39. Current options in antifungal pharmacotherapy. Mohr J; Johnson M; Cooper T; Lewis JS; Ostrosky-Zeichner L Pharmacotherapy; 2008 May; 28(5):614-45. PubMed ID: 18447660 [TBL] [Abstract][Full Text] [Related]
40. Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again. Cooke KR Pediatr Transplant; 2005 Dec; 9 Suppl 7():25-36. PubMed ID: 16305615 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]